Xin Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xin Zhang has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Yong Liu
Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, China
27 shared publications - Diekuo Zhang
Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, China
22 shared publications - Guo Li
Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, China
22 shared publications - Huihong Chen
Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, China
22 shared publications - Shanhong Lu
Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, China
22 shared publications - Chao Liu
Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, China
21 shared publications
Latest Publications
- Open Access
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S8 from CRB2 Activates an Epigenetic Axis to Promote Ferroptosis in Head and Neck Squamous Cell Carcinoma
STAT4 knockdown attenuates ferroptosis inducer-mediated CRB2 upregulation
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S8 from CRB2 Activates an Epigenetic Axis to Promote Ferroptosis in Head and Neck Squamous Cell Carcinoma
STAT4 knockdown attenuates ferroptosis inducer-mediated CRB2 upregulation
- Open Access
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S10 from CRB2 Activates an Epigenetic Axis to Promote Ferroptosis in Head and Neck Squamous Cell Carcinoma
Overall survival Cox regression analysis
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S10 from CRB2 Activates an Epigenetic Axis to Promote Ferroptosis in Head and Neck Squamous Cell Carcinoma
Overall survival Cox regression analysis
- Open Access
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from CRB2 Activates an Epigenetic Axis to Promote Ferroptosis in Head and Neck Squamous Cell Carcinoma
CRB2 overexpression differentially regulates H4K20me2 occupancy at the SLC7A11 locus in Fadu cells
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from CRB2 Activates an Epigenetic Axis to Promote Ferroptosis in Head and Neck Squamous Cell Carcinoma
CRB2 overexpression differentially regulates H4K20me2 occupancy at the SLC7A11 locus in Fadu cells
- Open Access
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from CRB2 Activates an Epigenetic Axis to Promote Ferroptosis in Head and Neck Squamous Cell Carcinoma
Knockdown of CRB2 reduces the level of H4K20me2 by enhancing LSD1 expression
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from CRB2 Activates an Epigenetic Axis to Promote Ferroptosis in Head and Neck Squamous Cell Carcinoma
Knockdown of CRB2 reduces the level of H4K20me2 by enhancing LSD1 expression
- Open Access
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S9 from CRB2 Activates an Epigenetic Axis to Promote Ferroptosis in Head and Neck Squamous Cell Carcinoma
H4K20me2 ChIP-seq-differentially genes in LSD1(E8A)-overexpressing vs. NC Fadu cells
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S9 from CRB2 Activates an Epigenetic Axis to Promote Ferroptosis in Head and Neck Squamous Cell Carcinoma
H4K20me2 ChIP-seq-differentially genes in LSD1(E8A)-overexpressing vs. NC Fadu cells
- Open Access
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Data from CRB2 Activates an Epigenetic Axis to Promote Ferroptosis in Head and Neck Squamous Cell Carcinoma
Therapeutic activation of ferroptosis is a potential strategy to induce cell death in cancer. Deciphering the epigenetic regulation of ferroptosis could provide insights into effective approaches for enhancing ferroptosis in cancer cells. In this study, we identified CRB2 as an epigenetic modulator of ferroptosis in head and neck squamous cell carcinoma (HNSCC). CRB2 expression correlated with the expression of ferroptosis-related genes and improved prognosis in patients with HNSCC. Ferroptosis inducers erastin and RSL3 significantly increased CRB2 expression, and overexpression of CRB2 sensitized HNSCC to ferroptosis, suppressing growth in vitro and in vivo. CRB2 upregulation led to an increase in the dimethylation of histone H4 lysine 20 in the promoter region of the ferroptosis inhibitor SLC7A11, which epigenetically inhibited its transcription and induced ferroptosis in HNSCC. Mechanistically, CRB2 hindered the interaction between the E8A isoform of the histone lysine demethylase LSD1 and the deubiquitinase USP7, thereby facilitating the degradation of LSD1(E8A) and subsequently increasing histone H4 lysine 20 dimethylation levels. Taken together, these results indicate that CRB2 stimulates ferroptosis by activating an epigenetic axis, suggesting that the upregulation of CRB2 is a potential therapeutic strategy for HNSCC.Significance:CRB2 epigenetically inhibits SCL7A11-GPX4 signaling to promote ferroptosis and suppress tumor growth in head and neck squamous cell carcinoma, providing insights that could guide ferroptosis-activating treatment approaches.
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from CRB2 Activates an Epigenetic Axis to Promote Ferroptosis in Head and Neck Squamous Cell Carcinoma
Therapeutic activation of ferroptosis is a potential strategy to induce cell death in cancer. Deciphering the epigenetic regulation of ferroptosis could provide insights into effective approaches for enhancing ferroptosis in cancer cells. In this study, we identified CRB2 as an epigenetic modulator of ferroptosis in head and neck squamous cell carcinoma (HNSCC). CRB2 expression correlated with the expression of ferroptosis-related genes and improved prognosis in patients with HNSCC. Ferroptosis inducers erastin and RSL3 significantly increased CRB2 expression, and overexpression of CRB2 sensitized HNSCC to ferroptosis, suppressing growth in vitro and in vivo. CRB2 upregulation led to an increase in the dimethylation of histone H4 lysine 20 in the promoter region of the ferroptosis inhibitor SLC7A11, which epigenetically inhibited its transcription and induced ferroptosis in HNSCC. Mechanistically, CRB2 hindered the interaction between the E8A isoform of the histone lysine demethylase LSD1 and the deubiquitinase USP7, thereby facilitating the degradation of LSD1(E8A) and subsequently increasing histone H4 lysine 20 dimethylation levels. Taken together, these results indicate that CRB2 stimulates ferroptosis by activating an epigenetic axis, suggesting that the upregulation of CRB2 is a potential therapeutic strategy for HNSCC.Significance:CRB2 epigenetically inhibits SCL7A11-GPX4 signaling to promote ferroptosis and suppress tumor growth in head and neck squamous cell carcinoma, providing insights that could guide ferroptosis-activating treatment approaches.
- Open Access
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from CRB2 Activates an Epigenetic Axis to Promote Ferroptosis in Head and Neck Squamous Cell Carcinoma
Sequences of RNA and DNA oligo sequences in method
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from CRB2 Activates an Epigenetic Axis to Promote Ferroptosis in Head and Neck Squamous Cell Carcinoma
Sequences of RNA and DNA oligo sequences in method
- Open Access
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from CRB2 Activates an Epigenetic Axis to Promote Ferroptosis in Head and Neck Squamous Cell Carcinoma
Validating the role of CRB2 on ferroptosis by RSL3 in HNSCC cells
- 2 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from CRB2 Activates an Epigenetic Axis to Promote Ferroptosis in Head and Neck Squamous Cell Carcinoma
Validating the role of CRB2 on ferroptosis by RSL3 in HNSCC cells